Company / Current Liabilities per Share
Amylyx Pharmaceuticals, Inc. Current Liabilities per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.21
FY2025
5-year range
$0.21 / $6.64
FY2021-FY2025
Trend
-50.1%
vs FY2024
Sector context
#189 of 210
Health Care
What the data says
Among 210 Health Care companies, Amylyx Pharmaceuticals, Inc. is in the top 10% for current liabilities per share. Current Liabilities per Share has declined for 3 consecutive years, from $6.64 in FY2022 to $0.21 in FY2025.
Based on SEC 10-K filings.
0.21 in FY2025 with a 3-year CAGR of -68.6%.
Improved from $1.21 to $0.21 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -68.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 10% in Health CareTop 10% of 210This company $0.21 Sector average $23.79
▼
-99.1% below sector average
Key checks
Key Insights
- Amylyx Pharmaceuticals, Inc.'s current liabilities per share has declined for 3 consecutive years.
- In FY2025, current liabilities per share decreased 50.1% year-over-year.
- Ranks #189 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.21 | -50.1% |
| FY2024 | $0.41 | -65.8% |
| FY2023 | $1.21 | -81.7% |
| FY2022 | $6.64 | +151.4% |
| FY2021 | $2.64 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026